Actively Recruiting

Phase Not Applicable
Age: 40Years - 70Years
FEMALE
Healthy Volunteers
NCT06216496

Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer

Led by University Hospital, Grenoble · Updated on 2024-05-20

23

Participants Needed

1

Research Sites

142 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Ovarian cancer is associated with undernutrition in more than half of all cases. The current management of undernutrition-cachexia in cancer is not specific. It is well recognized that the nutritional support currently offered to cancer patients is not effective in combating cachexia, which progresses inexorably, leading to the patient's death. It is therefore necessary to offer specific and adapted care, in particular by optimizing the quality of nitrogen intake. To achieve this, the investigators first need to define the specific amino acid requirements of cancer patients.

CONDITIONS

Official Title

Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer

Who Can Participate

Age: 40Years - 70Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Histological diagnosis of high-grade serous ovarian cancer not immediately resectable (stage III or IVa) managed at Grenoble Alpes University Hospital
  • Affiliation to the French social security system
  • Able to understand and follow the instructions necessary for the conduct of the trial
  • Provided written consent for the study
Not Eligible

You will not qualify if you...

  • Significant active comorbidity requiring long-term drug treatment (e.g. organ failure, diabetes) or history of conditions affecting amino acid metabolism (e.g. urea or homocysteine cycle abnormalities, tyrosinemia, alkaptonuria, hyperprolinemia, organic aciduria)
  • Vegetarian or vegan diet
  • Difficult venous access
  • Protected persons such as pregnant women, nursing mothers, persons deprived of liberty, or those under legal protection
  • Received over 4,500 euros compensation for other human research participation in the past 12 months
  • Significant unexplained biological abnormalities
  • Presence of liver metastases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU Grenoble Alpes

La Tronche, France

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here